Estimation of the Number of Patients With Mitochondrial Diseases: A Descriptive Study Using a Nationwide Database in Japan

Background To provide a better healthcare system for patients with mitochondrial diseases, it is important to understand the basic epidemiology of these conditions, including the number of patients affected. However, little information about them has appeared in Japan to date. Methods To gather data of patients with mitochondrial diseases, we estimated the number of patients with mitochondrial diseases from April 2018 through March 2019 using a national Japanese health care claims database, the National Database (NDB). Further, we calculated the prevalence of patients, and sex ratio, age class, and geographical distribution. Results From April 2018 through March 2019, the number of patients with mitochondrial diseases was 3,629, and the prevalence was 2.9 (95% confidence interval [CI], 2.8–3.0) per 100,000 general population. The ratio of females and males was 53 to 47, and the most frequent age class was 40–49 years old. Tokyo had the greatest number of patients with mitochondrial diseases, at 477, whereas Yamanashi had the fewest, at 13. Kagoshima had the highest prevalence of patients with mitochondrial diseases, 8.4 (95% CI, 7.1–10.0) per 100,000 population, whereas Yamanashi had the lowest, 1.6 (95% CI, 0.8–2.7). Conclusion The number of patients with mitochondrial diseases estimated by this study, 3,269, was more than double that indicated by the Japanese government. This result may imply that about half of all patients are overlooked for reasons such as low severity of illness, suggesting that the Japanese healthcare system needs to provide additional support for these patients.

[1]  R. Horvath,et al.  Revisiting mitochondrial diagnostic criteria in the new era of genomics , 2017, Genetics in Medicine.

[2]  Robert W. Taylor,et al.  Recent Advances in Mitochondrial Disease. , 2017, Annual review of genomics and human genetics.

[3]  Marni J. Falk,et al.  Hospitalizations for mitochondrial disease across the lifespan in the U.S. , 2017, Molecular genetics and metabolism.

[4]  M. Wakakura,et al.  Nationwide epidemiological survey of Leber hereditary optic neuropathy in Japan , 2017, Journal of epidemiology.

[5]  Eri Maeda,et al.  Estimation of the number of children with cerebral palsy using nationwide health insurance claims data in Japan , 2017, Developmental medicine and child neurology.

[6]  S. Pavlakis,et al.  Mitochondrial Diseases: A Clinical and Molecular History. , 2016, Pediatric Neurology.

[7]  L. Ward,et al.  Stress and coping of parents caring for a child with mitochondrial disease. , 2016, Applied nursing research : ANR.

[8]  Robert W. Taylor,et al.  Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease , 2015, Annals of neurology.

[9]  K. Majamaa,et al.  Prevalence of the primary LHON mutations in Northern Finland associated with bilateral optic atrophy and tobacco‐alcohol amblyopia , 2013, Acta ophthalmologica.

[10]  秀一 八ツ賀.  MELAS : a nationwide prospective cohort study of 96 patients in Japan , 2012 .

[11]  R. Whittaker,et al.  Mitochondrial diseases in childhood: a clinical approach to investigation and management , 2010, Developmental medicine and child neurology.

[12]  I. T. de Almeida,et al.  Pediatric mitochondrial respiratory chain disorders in the Centro region of Portugal. , 2009, Pediatric neurology.

[13]  P. Chinnery,et al.  Pathogenic Mitochondrial DNA Mutations Are Common in the General Population , 2008, American journal of human genetics.

[14]  Robert W. Taylor,et al.  Prevalence of mitochondrial DNA disease in adults , 2008, Annals of neurology.

[15]  M. Castro‐Gago,et al.  Epidemiology of pediatric mitochondrial respiratory chain disorders in northwest Spain. , 2006, Pediatric neurology.

[16]  K. Majamaa,et al.  Prevalence of large-scale mitochondrial DNA deletions in an adult Finnish population , 2005, Neurology.

[17]  Robert W. Taylor,et al.  The epidemiology of mitochondrial disorders--past, present and future. , 2004, Biochimica et biophysica acta.

[18]  J. Arenas,et al.  Prevalence and progression of mitochondrial diseases: A study of 50 patients , 2003, Muscle & nerve.

[19]  D. Thorburn,et al.  Minimum birth prevalence of mitochondrial respiratory chain disorders in children. , 2003, Brain : a journal of neurology.

[20]  D. Turnbull,et al.  The epidemiology of Leber hereditary optic neuropathy in the North East of England. , 2003, American journal of human genetics.

[21]  E. Holme,et al.  The incidence of mitochondrial encephalomyopathies in childhood: Clinical features and morphological, biochemical, and DNA abnormalities , 2001, Annals of neurology.

[22]  D. Turnbull,et al.  The epidemiology of pathogenic mitochondrial DNA mutations , 2000, Annals of neurology.

[23]  K. Majamaa,et al.  Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: prevalence of the mutation in an adult population. , 1998, American journal of human genetics.